Medicare Benefits Schedule - Item 31537

Search Results for Item 31537

View Associated Notes

Category 3 - THERAPEUTIC PROCEDURES

31537

31537 - Additional Information

Item Start Date:
01-Mar-2024
Description Updated:
01-Mar-2024
Schedule Fee Updated:
01-Mar-2024

Group
T8 - Surgical Operations
Subgroup
1 - General

Insertion of a marker clip into a breast, including axilla, following a breast biopsy and using imaging (but not including the associated imaging), if additional surgery, neoadjuvant systemic therapy, follow up imaging or radiation may be required and the insertion is for any of the following reasons:

(a) to mark the site of a lesion that has been totally or almost completely removed;

(b) to confirm biopsy site if multiple lesions are present;

(c) to confirm biopsy site of an ill-defined lesion;

(d) future surgery or preoperative localisation is considered to be potentially difficult due to lesion conspicuity;

(e) preoperative localisation is likely to be carried out using a modality different from the biopsy modality;

(f) for correlation across modalities for diagnostic reasons

 

Multiple Operation Rule

(Anaes.)

Fee: $208.50 Benefit: 75% = $156.40 85% = $177.25

(See para TN.8.280 of explanatory notes to this Category)


Associated Notes

Category 3 - THERAPEUTIC PROCEDURES

TN.8.280

Localisation of lesions in the breast and or axilla (items 31536 and 31537)

MBS item 31536 is for the preoperative insertion of a hookwire (or a similar device) into the breast or axilla to mark the site of a lesion, when the insertion is not associated with a breast biopsy. The hookwire (or similar device) is to be inserted under imaging which is billed under a separate MBS item.

MBS item 31537 is for the insertion of a marker clip (or tissue marker) into the breast and/or axilla, to mark the site of lesion that has been totally or almost removed at biopsy and requires localisation.

In accordance with accepted clinical practice guidelines, marker clips (or tissue markers) are not required for every biopsy and the particular occasions where they should be inserted are listed in MBS item 31537 (a) – (f). Please note the requirement at d) includes where neoadjuvant therapy may occur prior to future interventions on the breast and there is potential lack of lesion conspicuity following completion of neoadjuvant therapy.

For further information practitioners could refer to the accepted clinical guidance for the use of marker clips that is provided by BreastScreen Australia and Assessment Services.

Related Items: 31500 31503 31506 31509 31515 31536 31537


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change